News
-
-
-
-
-
-
-
-
PRESS RELEASE
Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer
Immunic appoints Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer, bringing extensive experience in neurology drug development and regulatory approvals. Company transitions into a fully integrated commercial-stage entity -
PRESS RELEASE
EQS-Adhoc: TIN INN Holding AG: TIN INN Holding AG enters into framework agreements with institutional investor for development of up to 20 hotel locations
TIN INN Holding AG enters into framework agreements with institutional investor for the development of up to 20 hotel locations, representing potential construction revenue volume of EUR 35-40 million -